The central theme of the EMBL Australia 2015 Symposium is “Completing the pipeline: from biology to bioinformatics and back again”. This Symposium will focus on exposing students to research that explores fundamental biological questions on a grander scale, using techniques such as 'next-generation' sequencing, mass spectrometry and lipidomics, or by using large cohort studies. Additionally, the symposium will focus on strategies for validating results and translating this information into new therapeutic treatment strategies.
Carrying on from the success of the inaugural 2014 EMBL PhD Symposium, held at the University of New South Wales, December 3-5th 2014, the 2015 Symposium will continue to develop a national network of students and early career researchers in Australia. The Symposium follows a format that is already highly successful in Europe, and will include plenary speakers, oral and poster presentations from PhD students and early career researchers, as well as informal blackboard and workshop sessions with keynote speakers.
The EMBL Australia PhD Symposium is organised by students associated with EMBL from universities, institutes and hospitals around Australia. The three day Symposium will be held at the Bio21 Institute, Melbourne, Australia and will receive participants from around the world. The exciting blend of research topics and speakers will engage scientists from broad fields. The addition of informal blackboard sessions with experienced plenary speakers offers an invaluable opportunity for delegates to meet and exchange ideas with peers and senior scientists, fostering long-term associations and professional relationships and collaborations.
The inaugural 2014 EMBL Australia PhD Symposium, held at the the University of NSW, Sydney, was a huge success. Titled "Research in life sciences: in vitro to in vivo", it was a fantastic opportunity for students to present their work to peers and senior scientists. The symposium explored the use of new technologies and techniques being developed to conceptually and practically model disease.
Keynote speakers included Prof Ian Fraser, Prof Marc Wilkins and A/Prof Jose Polo.